| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000044443 |
| Receipt No. | R000050774 |
| Scientific Title | Risk factors and overcoming strategies of surgical site infection after liver resection for colorectal liver metastases : A retrospective cohort study |
| Date of disclosure of the study information | 2021/06/05 |
| Last modified on | 2021/06/05 (Ver. 1) |
| Basic information | ||
| Public title | Risk factors and overcoming strategies of surgical site infection after liver resection for colorectal liver metastases : A retrospective cohort study | |
| Acronym | Risk factors and overcoming strategies of surgical site infection after liver resection for colorectal liver metastases : A retrospective cohort study | |
| Scientific Title | Risk factors and overcoming strategies of surgical site infection after liver resection for colorectal liver metastases : A retrospective cohort study | |
| Scientific Title:Acronym | Risk factors and overcoming strategies of surgical site infection after liver resection for colorectal liver metastases : A retrospective cohort study | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal liver metastases (CRLM) | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study was to investigate risk factors of SSI in patients who underwent liver resection for CRLM and to establish methods to reduce the prevalence of SSI which may lead to improved prognosis. |
| Basic objectives2 | Others |
| Basic objectives -Others | The purpose of this study was to investigate risk factors of SSI in patients who underwent liver resection for CRLM and to establish methods to reduce the prevalence of SSI which may lead to improved prognosis. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of SSI |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Between May 2007 and March 2020, 151 consecutive patients with CRLM who underwent an initial liver resection. | |||
| Key exclusion criteria | Staged hepatectomies. | |||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | Division of Hepatobiliary and Pancreas Surgery, Department of Surgery | ||||||
| Zip code | 105-8461 | ||||||
| Address | 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan | ||||||
| TEL | 03-3433-1111 | ||||||
| toruikegamijikei@jikei.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | Division of Hepatobiliary and Pancreas Surgery, Department of Surgery | ||||||
| Zip code | 105-8461 | ||||||
| Address | 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan | ||||||
| TEL | 03-3433-1111 | ||||||
| Homepage URL | |||||||
| k-furukawa@jikei.ac.jp | |||||||
| Sponsor | |
| Institute | The Jikei University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | the Ethics Committee of the Jikei University School of Medicine |
| Address | 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan |
| Tel | 03-3433-1111 |
| rinri@jikei.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 151 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We investigated the relationship between the patient characteristics and perioperative factors and the incidence of SSI. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050774 |